Invasive infections due to streptococcus Pyogenes: Seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012

Eurosurveillance

Volumn 19, Issue 17, 2014, Pages

  Olafsdottir, L B ^a   Erlendsdottir H ^a,b   Melo Cristino, J ^c   Weinberger, D M ^d,e   Ramirez, M ^c   Kristinsson, K G ^a,b   Gottfredsson, M ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c UNIVERSITY OF LISBON   (Portugal)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; EMM GENE; FEMALE; GENE SEQUENCE; GROUP A STREPTOCOCCAL INFECTION; HUMAN; ICELAND; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; NEWBORN; NONHUMAN; RETROSPECTIVE STUDY; SEASONAL VARIATION; STREPTOCOCCUS PYOGENES; VERY ELDERLY;

EID: 84899873179     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.17.20784     Document Type: Article

References (35)

1. Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother. 2000; 45 Suppl: 2-3. http://dx.doi.org/10.1093/jac/45.suppl_1.3
2. O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, et al. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis. 2002;35(3):268-76. http://dx.doi.org/10.1086/341409
3. Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis. 1992;14(1):2-11. http://dx.doi.org/10.1093/clinids/14.1.2
4. Centers of Disease Control and Prevention (CDC). CDC Streptococcus Laboratory. Atlanta: CDC. [Accessed: May 2012]. Available from: http://www.cdc.gov/ncidod/biotech/strep/strepindex.htm
5. Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E, et al. Emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis. 1999;5(2):247-53. http://dx.doi.org/10.3201/eid0502.990209
6. Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol. 2008;46(1):79-86. http://dx.doi.org/10.1128/JCM.01626-07
7. Meisal R, Andreasson IK, Hoiby EA, Aaberge IS, Michaelsen TE, Caugant DA. Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles. J Clin Microbiol. 2010;48(3):842-51. http://dx.doi.org/10.1128/JCM.01312-09
8. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, et al. Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis. 2005;192(5):771-82. http://dx.doi.org/10.1086/432514
9. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA. 1993;269(3):390-391. http://dx.doi.org/10.1001/jama.269.3.390 http://dx.doi.org/10.1001/jama.1993.03500030088038
10. Aebi C, Ahmed A, Ramilo O. Bacterial complications of primary varicella in children. Clin Infect Dis. 1996;23(4):698-705. http://dx.doi.org/10.1093/clinids/23.4.698
11. Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalen C, et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis. 2007;45(4):450-8. http://dx.doi.org/10.1086/519936
12. Gunnlaugsson S, Kristinsson KG, Steingrimsson O. Results of cultures and serotyping of S. pyogenes 1986-1993. Laeknabladid. 1995;81(10):728-32.
13. Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2008 Jul;46(7):2359-67. http://dx.doi.org/10.1128/JCM.00422-08
14. Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2009;47(4):1155-65. http://dx.doi.org/10.1128/JCM.02155-08
15. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011. J Clin Microbiol. 2013;51(3):841-8. http://dx.doi.org/10.1128/JCM.02566-12
16. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol. 2002;40(9):3489-92. http://dx.doi.org/10.1128/JCM.40.9.3489-3492.2002
17. Centers for Disease Control and Prevention (CDC). Protocol for emm typing. Streptococcus pyogenes emm sequence database. Atlanta: CDC. [Accessed: April 2011]. Available from: http://www.cdc.gov/ncidod/biotech/strep/protocol_emm-type.htm
18. Population by sex and age 1841-2014. Reykjavik: Statistics Iceland; 2012. [Accessed: Jan 2013]. Available from: http://statice.is/?PageID=1170&src=https://rannsokn.hagstofa.is/pxen/Dialog/varval.asp?ma=MAN00101%26ti=Population+by+sex+and+age+1841%2D2014+++%26path=./Database/mannfjoldi/Yfirlit/%26lang=1%26units=Number
19. Weinberger DM, Krause TG, Molbak K, Cliff A, Briem H, Viboud C, et al. Influenza epidemics in Iceland over 9 decades: changes in timing and synchrony with the United States and Europe. Am J Epidemiol. 2012;176(7):649-55. http://dx.doi.org/10.1093/aje/kws140
20. Serfling RE. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Rep. 1963;78(6):494-506. http://dx.doi.org/10.2307/4591848
21. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685-694. http://dx.doi.org/10.1016/S1473-3099(05)70267-X
22. World Health Organization (WHO). Measles. Geneva: WHO. [Accessed April 2011]. Available from: http://www.who.int/mediacentre/factsheets/fs286/en/
23. Vallalta Morales M, Soriano Navarro CJ, Salavert Lleti M, Montero Alonso M, Perez Belles C, Lopez Aldeguer J, et al. Group A streptococcal bacteremia: outcome and prognostic factors. Rev Esp Quimioter. 2006;19(4):367-75.
24. Lamagni TL, Neal S, Keshishian C, Powell D, Potz N, Pebody R, et al. Predictors of death after severe Streptococcus pyogenes infection. Emerg Infect Dis. 2009;15(8):1304-7. http://dx.doi.org/10.3201/eid1508.090264
25. Cleary PP, Kaplan EL, Handley JP, Wlazlo A, Kim MH, Hauser AR, et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet. 1992;339(8792):518-521. http://dx.doi.org/10.1016/0140-6736(92)90339-5
26. Aziz RK, Kansal R, Abdeltawab NF, Rowe SL, Su Y, Carrigan D, et al. Susceptibility to severe Streptococcal sepsis: use of a large set of isogenic mouse lines to study genetic and environmental factors. Genes Immun. 2007;8(5):404-15. http://dx.doi.org/10.1038/sj.gene.6364402
27. Nooh MM, Nookala S, Kansal R, Kotb M. Individual genetic variations directly effect polarization of cytokine responses to superantigens associated with streptococcal sepsis: implications for customized patient care. J Immunol. 2011;186(5):3156-63. http://dx.doi.org/10.4049/jimmunol.1002057
28. Cady A, Plainvert C, Donnio PY, Loury P, Huguenet D, Briand A, et al. Clonal spread of Streptococcus pyogenes emm44 among homeless persons, Rennes, France. Emerg Infect Dis. 2011;17(2):315-7. http://dx.doi.org/10.3201/eid1702.101022
29. Tyrrell GJ, Lovgren M, St Jean T, Hoang L, Patrick DM, Horsman G, et al. Epidemic of group A Streptococcus M/emm59 causing invasive disease in Canada. Clin Infect Dis. 2010;51(11):1290-7. http://dx.doi.org/10.1086/657068
30. Lintges M, van der Linden M, Hilgers RD, Arlt S, Al-Lahham A, Reinert RR, et al. Superantigen genes are more important than the emm type for the invasiveness of group A Streptococcus infection. J Infect Dis. 2010;202(1):20-8. http://dx.doi.org/10.1086/653082
31. Dowell SF. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerg Infect Dis. 2001;7(3):369-74. http://dx.doi.org/10.3201/eid0703.010301 http://dx.doi.org/10.3201/eid0703.017301
32. Jean C, Louie JK, Glaser CA, Harriman K, Hacker JK, Aranki F, et al. Invasive group A streptococcal infection concurrent with 2009 H1N1 influenza. Clin Infect Dis.2010;50(10):e59-62. http://dx.doi.org/10.1086/652291
33. Tasher D, Stein M, Simoes EA, Shohat T, Bromberg M, Somekh E. Invasive bacterial infections in relation to influenza outbreaks, 2006-2010. Clin Infect Dis. 2011;53(12):1199-207. http://dx.doi.org/10.1093/cid/cir726
34. Lang PO, Samaras N, Samaras D, Aspinall R. How important is vitamin D in preventing infections? Osteoporos Int. 2013;24(5):1537-53. http://dx.doi.org/10.1007/s00198-012-2204-6
35. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA. 2005;294(18):2336-41. http://dx.doi.org/10.1001/jama.294.18.2336